Want to see CATX full AI Analyst Report?
Perspective Therapeutics (CATX) Q2 2024 Earnings Report
CATX Q2 2024 EPS Results
- Actual EPS
- -$0.18
- Consensus EPS
- -$0.21
- Beat/Miss
- Beat by +$0.03
- One Year Ago EPS
- -$0.40
CATX Q2 2024 Revenue Results
- Actual Revenue
- $526.00K
- Expected Revenue
- $183.00K
- Beat/Miss
- Beat by +$343.00K
- YoY Revenue Growth
- -74.81%
Earnings Announcement Details
- Quarter
- Q2 2024
- Date
- 08/12/2024
- Time
- After Close
- Conference Call
- Monday, August 12, 2024
CATX Upcoming Earnings
Perspective Therapeutics's next earnings date is estimated for November 17, 2026, based on past reporting schedules.
Q2 2024 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2024 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2024 Earnings Call Summary
No earnings call summary is available for this earnings event.
CATX Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 17, 2026 | 2026 (Q3) | -0.24- | -0.35 | ― | ― |
| Aug 10, 2026 | 2026 (Q2) | -0.25-0.22 | -0.3 | 26.67% (+0.08) | |
| May 11, 2026 | 2026 (Q1) | -0.29-0.25 | -0.25 | 0.00% (+0.00) | |
| Mar 16, 2026 | 2025 (Q4) | -0.36-0.51 | -0.57 | 10.53% (+0.06) | |
| Nov 10, 2025 | 2025 (Q3) | -0.32-0.35 | -0.21 | -66.67% (-0.14) | |
| Aug 13, 2025 | 2025 (Q2) | -0.29-0.30 | -0.18 | -66.67% (-0.12) | |
| May 12, 2025 | 2025 (Q1) | -0.30-0.25 | -0.2 | -25.00% (-0.05) | |
| Mar 26, 2025 | 2024 (Q4) | -0.27-0.57 | -0.65 | 12.31% (+0.08) | |
| Nov 12, 2024 | 2024 (Q3) | -0.21-0.21 | -0.4 | 47.50% (+0.19) | |
| Aug 12, 2024 | 2024 (Q2) | -0.21-0.18 | -0.4 | 55.00% (+0.22) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
